Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: Results of a meta-analysis

Critical Care

Volumn 10, Issue 2, 2006, Pages

  Davidson, Warren J ^a   Dorscheid, Del ^a,b   Spragg, Roger ^c   Schulzer, Michael ^a   Mak, Edwin ^a   Ayas, Najib T ^a,b,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Intensive Care Unit Providence Healthcare   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VANCOUVER COASTAL HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; BERACTANT; DIPALMITOYLPHOSPHATIDYLCHOLINE; LUCINACTANT; LUSUPULTIDE; PLACEBO; LUNG SURFACTANT;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL LITERATURE; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; OXYGEN TENSION; OXYGENATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; TREATMENT DURATION; VARIANCE; ADULT; COMPARATIVE STUDY; PATHOPHYSIOLOGY; REVIEW;

ADULT; HUMANS; PULMONARY SURFACTANTS; RANDOMIZED CONTROLLED TRIALS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 33747650519     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc4851     Document Type: Article

References (34)

1. Günther A Ruppert C Schmidt R Markart P Grimminger F Walmrath D Seeger W Surfactant alteration and replacement in acute respiratory distress syndrome Respir Res 2001 2 353-364 10.1186/rr86 11737935 64803
2. National Heart and Lung Institute Task force on problems, research approaches, needs: The lung program. Publication No. (NIII) 73-432 Washington, DC: Department of Health, Education, and Welfare 1972 165-180
3. Lewis JF Veldhuizen R The role of exogenous surfactant in the treatment of acute lung injury Annu Rev Physiol 2003 65 613-642 10.1146/ annurev.physiol.65.092101.142434 12517997
4. Lewis JF Brackenbury A Role of exogenous surfactant in acute lung injury Crit Care Med 2003 31 4 Suppl S324-S328 10.1097/ 01.CCM.0000057911.19145.9F 12682460
5. Ware LB Matthay MA The acute respiratory distress syndrome N Engl J Med 2000 342 1334-1349 10.1056/NEJM200005043421806 10793167
6. The Acute Respiratory Distress Syndrome Network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome N Engl J Med 2000 342 1301-1308 10.1056/NEJM200005043421801 10793162
7. The National Heart, Lung, and Blood Institute ARDS Clinical Trials Network Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome N Engl J Med 2004 351-327 336 10.1056/NEJMoa032193 15269312
8. Frerking I Gunther A Seeger W Pison U Pulmonary surfactant: Functions, abnormalities and therapeutic options Intensive Care Med 2001 27 1699-1717 10.1007/s00134-001-1121-5 11810113
9. Spragg RG Lewis J Surfactant therapy in the acute respiratory distress syndrome Acute Respiratory Distress Syndrome. Lung Biology and Health and Disease Series New York: Marcel Dekker Inc Matthay M 2003 179 533-562
10. Jadad AR Moore RA Carrol D Jenkinson C Reynolds DJM Gavaghan DJ McQuay H Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Controlled Clin Trials 1996 17 1-12 10.1016/ 0197-2456(95)00134-4 8721797
11. Wiswell TE Smith RM Katz LB Mastroianni L Wong DY Willms D Heard S Wilson M Hite RD Anzueto A Bronchopulmonary segmental lavage with surfaxin (KL4-Surfactant) for acute respiratory distress syndrome Am J Respir Crit Care Med 1999 160 1188-1195 10508806
12. Pallua N Warbanow K Noah EM Machens H-G Poets C Bernhard W Berger A Intrabronchial surfactant application in cases of inhalation injury: first results from patients with severe burns and ARDS Burns 1998 24 197-206 10.1016/S0305-4179(97)00112-5 9677021
13. Walmrath D Günther A Ghofrani HA Schermuly R Schneider T Grimminger F Seeger W Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis Am J Respir Crit Care Med 1996 154 57-62 8680699
14. Walmrath D Grimminger F Pappert D Knothe C Obertacke U Benzing A Gunther A Schmehl T Leuchte H Seeger W Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: Impact on gas exchange and haemodynamics Eur Respir J 2002 19 805-810 10.1183/09031936.02.00243402 12030717
15. Spragg RG Gilliard N Richman P Smith RM Hite RD Pappert D Robertson B Curstedt T Strayer D Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome Chest 1994 105 195-202 8031347
16. Weg JG Balk RA Tharratt RS Jenkinson SG Shah JB Zaccardelli D Horton J Pattishall EN Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome JAMA 1994 272 1433-1438 10.1001/jama.272.18.1433 7933425
17. Anzueto A Baughman RP Guntupalli KK Weg JG Wiedemann HP Raventos AA Lemaire F Long W Zaccardelli D Pattishall EN Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group N Engl J Med 1996 334 1417-1421 10.1056/NEJM199605303342201 8618579
18. Gregory TJ Steinberg KP Spragg R Gadek JE Hyers TM Longmore WJ Moxley MA Cai GZ Hite RD Smith RM Bovine surfactant therapy for patients with acute respiratory distress syndrome Am J Respir Crit Care Med 1997 155 1309-1315 9105072
19. Spragg RG Lewis JF Wurst W Hafner D Baughman RP Wewers MD Marsh JJ Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant Am J Respir Crit Care Med 2003 167 1562-1566 10.1164/rccm.200207-782OC 12649125
20. Spragg RG Lewis JF Walmrath D Johannigman J Bellingan G Laterre PF Witte MC Richards GA Rippin G Rathgeb F Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome N Engl J Med 2004 351 884-892 10.1056/NEJMoa033181 15329426
21. Gregory TJ Hite RD Hicklin G Reardon C Kinasewitz G Heard S Apostolakos M Fletcher EC Tsai H Schaber CJ Dose escalation study of surfaxin delivered via bronchopulmonary segmental lavage (BPSL) in patients with ARDS [abstract] Am J Respir Crit Care Med 2003 167 A178
22. Kesecioglu J Schultz MJ Lundberg D Lauven PM Lachmann B Treatment of acute lung injury (ALI/ARDS) with surfactant [abstract] Am J Respir Crit Care Med 2001 163 A819
23. Spragg RG Lewis JF Rathgeb F Hafner D Seeger W Intratracheal instillation of rSP-C surfactant improves oxygenation in patients with ARDS [abstract] Am J Respir Crit Care Med 2002 165 A22
24. Spragg RG Harris KW Lewis J Marsh JJ Wurst W Rathgeb F Surfactant treatment of patients with ARDS may reduce acute lung inflammation [abstract] Am J Respir Crit Care Med 2001 163 A23
25. Walmrath D De Vaal JB Bruining HA Kilian JG Papazian L Hohlfeld J Vogelmeier C Wurst W Schaffer P Rathgeb F Treatment of ARDS with a recombinant SP-C (rSP-C) based synthetic surfactant [abstract] Am J Respir Crit Care Med 2000 161 A379
26. MacIntyre NR Coleman RE Schuller FS Zaccardelli D Pattishall E Efficiency of the delivery of aerosolized artificial surfactant in intubated patients with the adult respiratory distress syndrome [abstract] Am J Respir Crit Care Med 1994 149 A125
27. Reines HD Silverman H Hurst J Warren J Williams J Rotello L Horton J Pattishall E Effects of two concentrations of nebulized surfactant (Exosurf) in sepsis-induced adult respiratory distress syndrome (ARDS) [abstract] Crit Care Med 1992 20 S61
28. Adhikari N Burns KEA Meade MO Pharmacologic treatments for acute respiratory distress syndrome and acute lung injury: Systematic review and meta-analysis Treatments Respir Med 2004 3 307-382 10.2165/ 00151829-200403050-00005
29. Frerking I Gunther A Seeger W Pison U Pulmonary surfactant: Functions, abnormalities and therapeutic options Intensive Care Med 2001 27 1699-1717 10.1007/s00134-001-1121-5 11810113
30. Cranshaw J Griffiths MJD Evans TW The pulmonary physician in critical care: Non-ventilatory strategies in ARDS Thorax 2002 57 823-829 10.1136/ thorax.57.9.823 12200529
31. Willson DF Thomas NJ Markovitz BP Pediatric Acute Lung Injury and Sepsis Investigators Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: A randomized controlled trial JAMA 2005 293 470-476 10.1001/jama.293.4.470 15671432
32. Derdak S Mehta S Stewart TE Smith T Rogers M Buchman TG Carlin B Lowson S Granton J the Multicenter Oscillatory Ventilation for Acute Respiratory Distress Syndrome Trial (MOAT) Study Investigators High-frequency oscillatory ventilation for acute respiratory distress syndrome in adults - a randomized, controlled trial Am J Respir Crit Care Med 2002 166 801-808 10.1164/rccm.2108052 12231488
33. Gattinoni L Tognoni G Pesenti A Taccone P Mascheroni D Labarta V Malacrida R Di Giulio P Fumagalli R Pelosi P for the Prone-Supine Study Group Effect of prone positioning on the survival of patients with acute respiratory failure N Engl J Med 2001 345 568-573 10.1056/NEJMoa010043 11529210
34. Cordingley JJ Keogh BF The pulmonary physician in critical care. 8: ventilatory management of ALI/ARDS Thorax 2002 57 729-734 10.1136/ thorax.57.8.729 12149536